Clinical Trial

Validation of Continuous Monitoring of Vital Signs in Children With a Connected Patch

Study acronym: VITALPICU
Recruiting
View on ClinicalTrials.gov →
Summary
Small connected devices monitoring vital signs do not exist in children although they could be very useful to monitor patients once they have left the pediatric intensive care unit (PICU) in order to early identify patients at risk of PICU readmission. The main objective of this study is to assess the accuracy of a connected thoracic patch (VT-Patch) for the continuous monitoring of vital signs in PICU patients. This monitoring device will be used to monitor children in PICU for 8 hours and results will be compared to the standard of care in the unit which is the Philips monitoring system. The investigators will assess the device's accuracy for the monitoring of 4 vital signs (SpO2, heart rate, respiratory rate and temperature) and perform exploratory assessment of three additional parameters (EKG, blood pressure and movement capture). The skin colour of each participant will be categorized based on Fitzpatrick scale and non-invasive spectroscopic method.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-11-09; most recent amendment 2025-12-11.
Status change: Not Yet Recruiting → Recruiting 2025-02-21
Trial Details
NCT Number NCT04627766
Lead Sponsor St. Justine's Hospital
Conditions Vital Signs
Enrollment 48 participants
Start Date 2025-02-02
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-18